In their interesting observational study Smith and Perner [1] describe fl uid resuscitation (FR) in 164 patients with septic shock, concluding that survival was better in patients receiving higher volumes over the fi rst 72 h. I think we should be cautious, however, to conclude from this that more is better.
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Median FR was 4.0 L over 24 h, and 7.5 L by 72 hrelatively small volumes for patients with ongoing shock. FR volumes reported from trials performed in septic shock are substantially larger despite comparable illness severity; mean FR over 72 h was approximately 19 L in the Vasopressin in Septic Shock Trial (VASST) study [2] , 13 L in the study by Rivers and colleagues [3] and 16 L in another recent study [4] . Indeed, median FR in the highvolume group (10.9 L at 72 h) was comparable to the lowest quartile, associated with the best prognosis, in the VASST study (16 L at 96 h) [2] . Th us, I do not believe that the benefi t of higher-volume FR described is in confl ict with the harm associated with larger volumes reported previously [2] . Similarly, median FR in the lower-volume group was only 4.3 L in 72 h. As FR was physiciandirected, lower-volume FR might have been indicated by factors like chronic cardiac failure or fl uid unresponsiveness associated with poorer outcomes irrespective of FR; no evidence is provided to conclude that increasing FR in this group would have improved survival.
Overall, this report records excellent outcomes using moderate FR by recent standards. Further trials are needed to characterize the dose and indications for FR in septic shock. 
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Th anks to Dr Prowle for his interest in our study. We agree that observations in cohort studies should be interpreted with caution, in particular in complex clinical settings such as fl uid resuscitation of patients with sepsis in the ICU. Th e interpretation of studies in this area is further complicated by diff erences in the reporting of fl uid therapy. Th e types of, and indications for, fl uids are most often not reported, so when previous trials [2] [3] [4] report that more than 10 L of fl uid was given by day 3, we do not know if this fl uid was given for resuscitation. In trials of fl uid resuscitation [5] (unpublished observations from the 6S trial [6] ), 2.5 L of other fl uids were given for each liter of resuscitation fl uid. Th e indications for giving other fl uids may include nutrition, maintenance, fl uids with medications and electrolytes or even to keep a drip open, but we do not know the details. Taken together, we support the notion that the controversy of fl uid volume in septic shock may only be resolved in randomized trials of higher versus lower fl uid volumes in these patients. Such trials should be top priority for the ICU research community.
Abbreviations FR, fl uid resuscitation; VASST, Vasopressin in Septic Shock Trial.
